Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Belluscura PLC (GB:BELL)
LSE:BELL
Holding GB:BELL?
Track your performance easily
BELL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range7.00p - 27.00p
Previous Close9.5p
Volume64.46K
Average Volume (3M)215.16K
Market Cap
£16.84M
Enterprise Value14.63M
Total Cash (Recent Filing)$2.04M
Total Debt (Recent Filing)$302.62K
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Feb 25, 2025EPS Estimate
-£0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding168,408,232
10 Day Avg. Volume133,078
30 Day Avg. Volume215,158
Standard Deviation0.25
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)66.67
Price to Sales (P/S)16.74
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit214.75
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Belluscura PLC News
PremiumCompany Announcements
Belluscura Secures $4 Million for Oxygen Device Expansion
PremiumCompany Announcements
Belluscura’s Shareholding Shift: RBC Increases Stake
PremiumCompany Announcements
Belluscura PLC Sees Revenue Surge with New Device Launch
PremiumCompany Announcements
Belluscura Reports Revenue Surge Amidst Net LossesPremiumCompany Announcements
Tekcapital Reduces Stake in Belluscura PLC
PremiumCompany Announcements
Belluscura PLC Announces Shareholding Change
PremiumCompany Announcements
Belluscura Shareholders Affirm Company Leadership
PremiumCompany Announcements
Belluscura Forecasts Strong Growth with New Oxygen TechBELL FAQ
What was Belluscura PLC’s price range in the past 12 months?
Belluscura PLC lowest share price was 7.00p and its highest was 27.00p in the past 12 months.
What is Belluscura PLC’s market cap?
Currently, no data Available
When is Belluscura PLC’s upcoming earnings report date?
Belluscura PLC’s upcoming earnings report date is Feb 25, 2025 which is in 95 days.
How were Belluscura PLC’s earnings last quarter?
Belluscura PLC released its earnings results on Sep 26, 2024. The company reported -0.032p earnings per share for the quarter, missing the consensus estimate of -0.024p by -0.009p.
Is Belluscura PLC overvalued?
According to Wall Street analysts Belluscura PLC’s price is currently Overvalued.
Does Belluscura PLC pay dividends?
Belluscura PLC does not currently pay dividends.
What is Belluscura PLC’s EPS estimate?
Belluscura PLC’s EPS estimate is -£0.02.
How many shares outstanding does Belluscura PLC have?
Belluscura PLC has 168,408,230 shares outstanding.
What happened to Belluscura PLC’s price movement after its last earnings report?
Belluscura PLC reported an EPS of -0.032p in its last earnings report, missing expectations of -0.024p. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Belluscura PLC?
Currently, no hedge funds are holding shares in GB:BELL
---
Belluscura PLC Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.22%
12-Months-Change
Fundamentals
Return on Equity
-85.77%
Trailing 12-Months
Asset Growth
-20.46%
Trailing 12-Months
Company Description
Belluscura PLC
Belluscura PLC is a medical device company. Its first product, the X-PLO?RTM, is a lightweight FDA cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO?R weighs less than 1.5kg (3.25lbs) and it is the first modular portable oxygen concentrator and that it will generate more oxygen by weight than any other FDA cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.
---
Technical Analysis
RUA Life Sciences
―
Tissue Regenix
―
HemoGenyx Pharmaceuticals Plc
―
EKF Diagnostics Holdings
―
---